Royal United Hospitals Bath NHS Foundation Trust

Specialist MDT: North Bristol NHS Trust

View Provider Services

Men diagnosed at this hospital trust can access the following services:

  • Diagnostic Facilities:
    • Multiparametric MRI
    • Transperineal biopsy under general anaesthetic
    • Choline PET
    • PSMA (prostate-specific membrane antigen) PET scan
    • Isotope bone scan
  • Treatment Facilities:
    • Laparoscopic prostatectomy
    • External beam radiotherapy
    • Intensity-modulated radiotherapy
    • Chemotherapy
    • Joint specialist MDT clinic
  • Support Service Facilities:
    • Prostate cancer clinical nurse specialist (PCa CNS)
    • Advanced PCa CNS
    • Urology CNS
    • Oncology CNS
    • Sexual function services
    • Specialist continence services
    • Psychological counselling

Data Quality

Diagnosing Trust Specialist MDT
No. of Cancer Registry records 288 1368
Performance Status recorded 85% 78%
PSA completed 88% 82%
Gleason Score completed 78% 81%
TNM completed 90% 78%
Multiparametric MRI performed 79% 80%
At least 1 treatment modality recorded 87% 93%

Disease Presentation

Specialist MDT National
No. of men with disease status determined 1277 39295
Percentage of men diagnosed with metastatic disease 16% 16%

Management

Specialist MDT National
No. of men diagnosed with low-risk localised disease 103 2581
Percentage of men with low-risk localised disease receiving radical treatment 3% 4%
No. of men diagnosed with locally advanced disease 505 15573
Percentage of men diagnosed with locally advanced disease receiving radical treatment 68% 68%
No. of men with high risk/locally advanced prostate cancer who received radiotherapy 214 6974
Percentage of men having radical radiotherapy for high-risk/locally advanced disease receiving a brachytherapy boost 14% 5%
No. of men diagnosed with N+ M0 (node positive, no metastases) 43 1821
Percentage of men diagnosed with N+ M0 (node positive, no metastases) receiving docetaxel 9% 14%
No. of men diagnosed with M1 (metastases) 204 6085
Percentage of men diagnosed with M1 (metastases) receiving docetaxel 28% 27%
Diagnosing Trust National
No. of men diagnosed with intermediate-risk disease 41 3457
Percentage of men diagnosed with intermediate-risk disease receiving a hypofractionated regimen 97% 91%
No. of men diagnosed with high-risk disease 68 6966
Percentage of men diagnosed with high-risk disease receiving a hypofractionated regimen 73% 59%

Outcome

Treatment Centre
No. of men who received radical prostatectomy (2017-2018) 51
Adjusted percentage of men who had an emergency readmission within 90 days of radical prostatectomy (%) 17%
No. of men who received radical prostatectomy (2016) 38
Adjusted percentage of men experiencing at least one GU complication (%) 6%
No. of men who received radical radiotherapy (2016) 111
Adjusted percentage of men experiencing at least one GI complication (%) 14%

Compare provider outcomes